The GEPIA database analysis showed that higher GJB2 expression was associated with worse OS outcomes in patients with ACC, CESC, GBM, KIRC, LUAD, and PAAD (all P < 0.05). The gene discussed is GJB2; the disease is pancreatic adenocarcinoma.